Skip to content
ppharmaranks
Menu
Class IOngoing

VitalityXtra Capsules recall

FDA recall D-0083-2025 · initiated Nov 4, 2024

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Dec 11, 2024How we research

Boulla LLC recalled VitalityXtra Capsules in Nov 2024 — an FDA Class I recall (D-0083-2025) because Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.

Most serious — a reasonable probability that use will cause serious harm or death.

Why it was recalled

Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.

Sold unapproved, or found to contain something undeclared

The product should not have been on sale in this form — often a supplement found to contain a hidden prescription drug.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot #: 230811, Exp: 08/11/2025

Quantity recalled: Unknown

Details

Product
VitalityXtra Capsules, 500 mg, packaged in 10 count blisters in cartons, Distributed by: VitalityXtra, San Francisco, CA www.vitalityxtra.com
Recalling company
Boulla LLC
Classification
Class I
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Nationwide within the United States
Initiated
Nov 4, 2024
FDA report date
Dec 11, 2024
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was VitalityXtra Capsules recalled?
Boulla LLC recalled VitalityXtra Capsules in Nov 2024 — an FDA Class I recall (D-0083-2025) because Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac. Most serious — a reasonable probability that use will cause serious harm or death.
Why was VitalityXtra Capsules recalled?
Per the FDA enforcement record, the reason for recall D-0083-2025 was: Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.
Is a recalled VitalityXtra Capsules dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. Most serious — a reasonable probability that use will cause serious harm or death. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of VitalityXtra Capsules are affected?
Distributed: Nationwide within the United States. The recall covers these lots — Lot #: 230811, Exp: 08/11/2025. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0083-2025.

Source: openFDA Drug Enforcement record D-0083-2025

← All drug recalls